FDG-PET and chemotherapy for successful diagnosis and treatment of cardiac metastasis from non-small cell lung cancer

Intern Med. 2012;51(14):1909-12. doi: 10.2169/internalmedicine.51.7330. Epub 2012 Jul 15.

Abstract

Non-small cell lung cancer was metastasized at the septal side of right atrium in 59-year-old woman who had undergone surgery for lung cancer 11 years ago. The cardiac metastasis was found by whole-body 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (FDG-PET/CT), and cytologically confirmed by myocardial aspiration biopsy with right heart catheterization. The patient was treated with 4 cycles of carboplatin/pemetrexed followed by maintenance therapy with pemetrexed. The metastatic cardiac tumor shrank, and the atrioventricular (AV) block in ECG was improved. In this case, FDG-PET and chemotherapy were valuable for diagnosis and treatment of cardiac metastasis from non-small cell lung cancer.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Carboplatin / administration & dosage
  • Carcinoma, Non-Small-Cell Lung / diagnostic imaging
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / secondary*
  • Electrocardiography
  • Female
  • Fluorodeoxyglucose F18
  • Glutamates / administration & dosage
  • Guanine / administration & dosage
  • Guanine / analogs & derivatives
  • Heart Neoplasms / diagnostic imaging
  • Heart Neoplasms / drug therapy
  • Heart Neoplasms / secondary*
  • Humans
  • Lung Neoplasms*
  • Middle Aged
  • Pemetrexed
  • Positron-Emission Tomography
  • Radiopharmaceuticals

Substances

  • Glutamates
  • Radiopharmaceuticals
  • Pemetrexed
  • Fluorodeoxyglucose F18
  • Guanine
  • Carboplatin